logo

For the Inventor, By the Inventor

Monmouth Junction, NJ, United States of America

Tris Pharma, Inc.


USPTO Granted Patents = 53



Trademarks = 12

Forward Citations = 2,205

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal Yu-Hsing Tu (44 out of 51 patents)

silverMedal Ketan Mehta (31 out of 31 patents)

bronzeMedal Ashok Perumal (18 out of 25 patents)

4.  Kalyan Kathala (15 out of 25 patents)

5.  Andrea Nelson (6 out of 6 patents)

6.  Sachin Vasant Chaudhari (5 out of 5 patents)

7.  Quin-Zene Chen (5 out of 5 patents)

8.  Harsh Mehta (5 out of 5 patents)

9.  Paras Rameshlal Jain (4 out of 4 patents)

10.  Mahendra Shah (2 out of 2 patents)

11.  Alivia Chaudhuri (1 out of 1 patent)

12.  Nemichand B Jain (1 out of 16 patents)

13.  Grishma Patel (1 out of 1 patent)

14.  Shivanand Puthli (1 out of 1 patent)

15.  Antonio Pardo (1 out of 1 patent)


Core Competencies:
Extended Release Tablets
Gastro-Retentive Systems
Modified Release Formulations
Drug-Ion Exchange Resin
Methylphenidate Compositions
Benzonatate Tablets
Clonidine Formulations
GHB Pharmaceutical Compositions
Floating Polymer Networks
Trigger Pulse Drug Release
Chewable Tablets
Aqueous Suspension Products

53 patents:

1. 12458592 - Extended release amphetamine tablets (2025-11-04),
2. 12201720 - Pharmaceutical composition comprising GHB gastro-retentive raft forming systems having trigger pulse drug release (2025-01-21),
3. 12076441 - Extended release amphetamine tablets (2024-09-03),
4. 11938224 - Benzonatate modified release solid tablets and capsules (2024-03-26),
5. 11918689 - Liquid clonidine extended release composition (2024-03-05),
6. 11890267 - Benzonatate modified release solid tablets and capsules (2024-02-06),
7. 11666546 - GHB pharmaceutical compositions comprising a floating interpenetrating polymer network forming system (2023-06-06),
8. 11633389 - Methylphenidate extended release chewable tablet (2023-04-25),
9. 11590228 - Extended release amphetamine compositions (2023-02-28),
10. 11590081 - Extended release amphetamine tablets (2023-02-28),
11. 11337920 - Pharmaceutical composition comprising GHB gastro-retentive raft forming systems having trigger pulse drug release (2022-05-24),
12. 11337919 - Modified release drug powder composition comprising gastro-retentive RAFT forming systems having trigger pulse drug release (2022-05-24),
13. 11241411 - Benzonatate modified release solid tablets and capsules (2022-02-08),
14. 11103495 - Methylphenidate extended release chewable tablet (2021-08-31),
15. 11103494 - Methylphenidate extended release chewable tablet (2021-08-31),
Tris Pharma, Inc. is a pharmaceutical company that specializes in developing and manufacturing innovative solutions for patients. With a focus on drug delivery technology, Tris Pharma aims to improve the effectiveness and convenience of medication for better patient outcomes. The company offers a wide range of products across various therapeutic areas and is committed to advancing healthcare through research and development.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

53 Patents

#2 in Monmouth Junction, NJ

#269 in New Jersey

#6,443 in US

#12,944 in the World

...
Monmouth Junction, NJ, United States of America

Tris Pharma, Inc.

Forward Citations = 2,205

15 inventors:

goldMedal Yu-Hsing Tu (44 out of 51 patents)

silverMedal Ketan Mehta (31 out of 31 patents)

bronzeMedal Ashok Perumal (18 out of 25 patents)

4.  Kalyan Kathala (15 out of 25 patents)

5.  Andrea Nelson (6 out of 6 patents)

Please report any incorrect information to support@idiyas.com
Loading…